Iobenguane

Iobenguane
Clinical data
Trade namesAdreview, Azedra
Other namesmeta-iodobenzylguanidine
mIBG, MIBG
License data
Routes of
administration
Intravenous
ATC code
Legal status
Legal status
Identifiers
  • 1-(3-iodobenzyl)guanidine
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC8H10IN3
Molar mass275.093 g·mol−1
3D model (JSmol)
  • C1=CC(=CC(=C1)I)CNC(=N)N
  • InChI=1S/C8H10IN3/c9-7-3-1-2-6(4-7)5-12-8(10)11/h1-4H,5H2,(H4,10,11,12) ☒N
  • Key:PDWUPXJEEYOOTR-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Iobenguane, or MIBG, is an aralkylguanidine analog of the adrenergic neurotransmitter norepinephrine (noradrenaline), typically used as a radiopharmaceutical.[3] It acts as a blocking agent for adrenergic neurons. When radiolabeled, it can be used in nuclear medicinal diagnostic and therapy techniques as well as in neuroendocrine chemotherapy treatments.

It localizes to adrenergic tissue and thus can be used to identify the location of tumors such as pheochromocytomas and neuroblastomas.[4] With iodine-131 it can also be used to treat tumor cells that take up and metabolize norepinephrine.

  1. ^ "Adreview- iobenguane i-123 injection". DailyMed. 10 March 2020. Retrieved 21 May 2022.
  2. ^ "Azedra- iobenguane i-131 injection, solution". DailyMed. 8 April 2021. Retrieved 21 May 2022.
  3. ^ Olecki E, Grant CN (December 2019). "MIBG in neuroblastoma diagnosis and treatment". Seminars in Pediatric Surgery. 28 (6): 150859. doi:10.1016/j.sempedsurg.2019.150859. PMID 31931960. S2CID 210191760.
  4. ^ Scarsbrook AF, Ganeshan A, Statham J, Thakker RV, Weaver A, Talbot D, et al. (2007). "Anatomic and functional imaging of metastatic carcinoid tumors". Radiographics. 27 (2): 455–477. doi:10.1148/rg.272065058. PMID 17374863.

From Wikipedia, the free encyclopedia · View on Wikipedia

Developed by Nelliwinne